作为皮肤黑色素瘤预后的TP53及其调节基因
Safir Ullah Khan1, Zahid Ullah2, Hadia Shaukat3
1Department of Cell Biology, Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City, Mexico.
Cancer informatics
|September 5, 2023
概括
这项研究揭示了皮肤黑色素瘤中p53信号基因 (包括TP53和CDKN2A) 的高突变率. 基因表达分析确定了关键的过度表达和过度表达的基因,表明了它们的预后潜力.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 皮肤黑色素瘤是一种具有复杂遗传基础的重大皮肤癌.
- p53信号通路在瘤抑制中起着至关重要的作用,并且在包括黑色素瘤在内的各种癌症中经常发生变化.
研究的目的:
- 在皮肤黑色素瘤中全面调查p53信号通路基因的基因突变和表达模式.
- 为了确定p53通路内的预后和治疗点的潜在生物标志物.
主要方法:
- 来自大型公共遗传数据库 (例如TCGA) 的突变和基因表达数据的分析.
- 对黑色素瘤组织,健康组织 (暴露于阳光和未暴露于阳光) 和黑色素瘤细胞系之间的基因配置进行比较.
- 基因表达,临床病理特征 (年龄,性别,结节状况) 和免疫细胞透之间的相关性分析.
主要成果:
- 在皮肤黑色素瘤中,TP53和CDKN2A是最常发生突变的基因.
- 在黑色素瘤中,TP53,MDM2,CDKN2A和TP53BP1的表达过度,而MDM4和CDKN2B的表达不足.
- 在黑色素瘤和健康组织之间,在不同组织暴露之间以及性别之间观察到基因表达的显著差异.
- MDM2表达与瘤阶段相关,一些p53通路基因与特定的免疫细胞类型有相关性.
- TP53,MDM2和CDKN2A与皮肤黑色素瘤特异性瘤免疫有关.
结论:
- 在皮肤黑色素瘤中,p53信号通路在突变和表达水平上都发生了显著的改变.
- 这一途径中的特定基因,如TP53,MDM2和CDKN2A,可能作为黑色素瘤预后和瘤免疫力的预测生物标志物.
- 通过体内和体外研究进行进一步的验证是有必要的,以证实这些发现.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K